Overcoming Drug Resistance in Gynecologic Cancers

<p>1. Introduction to gynecologic cancers: An emphasis on pathogenesis, incidence sand diagnosis</p> <p>2. Lifestyle, nutrition, and risk of gynecologic cancers</p> <p>3. Drug Resistance in Gynecologic Cancers: Findings and Underlying Mechanisms</p> <p>4. Mechanisms of Chemo-resistance and Approaches to Overcome its Impact in Gynecologic Cancers</p> <p>5. Drug resistance in gynecologic cancers: Findings and underlying mechanismsCurrent Treatment Modalities in Major Gynecologic Cancers: Emphasis on Response Rates</p> <p>6. Drug Resistance in Gynecologic Cancers: Emphasis on Non-coding RNAs and Drug Efflux Mechanisms </p> <p>7. Genetic Polymorphisms in Gynecologic Cancers</p> <p>8. Overcoming Drug Resistance in Cervical Cancer: Chemo-sensitizing Agents and Targeted Therapies </p> <p>9. Immune Response, Inflammation Pathway Gene Polymorphisms and the Risk of Cervical Cancer</p> <p>10. Overcoming Chemotherapy Resistance in Endometrial Cancer</p> <p>11. Chemoresistance in Uterine Cancer: Mechanisms of Resistance and Current Therapies</p> <p>12. Ovarian Cancer: Targeted Therapies and Mechanisms of Resistance</p> <p>13. Overcoming Drug Resistance in Ovarian Cancer: Chemo-sensitizing Agents, Targeted Therapies</p> <p>14. Resistance to Chemotherapy Among Ethnic and Racial Groups: Health Disparities Perspective in Gynecologic Cancers</p> <p>15. Future Perspectives and New Directions in Chemosensitizing Activities to Reverse Drug Resistance in Gynecologic Cancers: Emphasis on Challenges and Opportunities</p>